Investing Profile

Zhi Yang

InvestorVC
Managing Partner at BioVeda China Fund
Photo of Zhi Yang, Managing Partner at BVCF (Bioveda China Fund)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
855 CONNECTIONS
Harvard University Network
855 CONNECTIONS
cb
BVCF (Bioveda China Fund) Managing Partner
$100K - $5.0M
$1.5M
6
$188M
CompanyStageDateRound SizeTotal Raised
Qiselian Biotechnology
SeedApr 2025
Cellenkos
Series ANov 2021$15M
$15M
Oculis
Series CMay 2021$57M
$190M
Co-investors: Peter Bisgaard (Nan Fung Life Sciences), Rob Hopfner (Pivotal Life Sciences), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital)
DiaCarta
Series AJan 2015$8M
$8M
CARsgen Therapeutics
Series ANov 2014
Jaguar Health
Series AFeb 2014$7M
$7M
Managing Partner BioVeda China FundPresent
武汉大学 Bachelor of Science (BS) Virology
Harvard University Master of Arts (M.A.) Biology
Harvard University PhD Cellular and Development Biology
Sign in with Google →
Sign in with Google →